4512.T Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 Mai 2024 @ 08:15):

Stats
Tagesvolumen	27 000.00
Durchschnittsvolumen	152 208
Marktkapitalisierung	7.95B
EPS	¥0 ( 2024-02-05 )
Nächstes Ertragsdatum	( ¥0 ) 2024-05-12
Last Dividend	¥3.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	-44.64
ATR14	¥0.371 (0.16%)

Volumen Korrelation

Lang: 0.14 (neutral)

Kurz: -0.39 (neutral)

Signal:(39.173) Neutral

Wakamoto Pharmaceutical Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Wakamoto Pharmaceutical Korrelation - Währung/Rohstoff

-0.11
( neutral )

0.00
( neutral )

0.28
( neutral )

0.11
( neutral )

Wakamoto Pharmaceutical Finanzdaten

Annual	2022
Umsatz:	¥8.66B
Bruttogewinn:	¥4.11B (47.44 %)
EPS:	¥3.98

FY	2022
Umsatz:	¥8.66B
Bruttogewinn:	¥4.11B (47.44 %)
EPS:	¥3.98

FY	2022
Umsatz:	¥8.38B
Bruttogewinn:	¥4.36B (51.96 %)
EPS:	¥6.87

FY	2021
Umsatz:	¥8.89B
Bruttogewinn:	¥4.49B (50.45 %)
EPS:	¥-17.34

Financial Reports:

No articles found.

Wakamoto Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥0 (N/A)	¥3.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Wakamoto Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 5.84 - average (61.59%) | Divividend Growth Potential Score: 3.11 - Decrease likely (37.80%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥2.50	2001-03-27
Last Dividend	¥3.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	17	--
Total Paid Out	¥45.50	--
Avg. Dividend % Per Year	0.00%	--
Score	1.71	--
Div. Sustainability Score	5.84
Div.Growth Potential Score	3.11
Div. Directional Score	4.47	--

Next Divdend (Est)
(2025-02-24)

¥0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

1.71

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
7989.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
7226.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
6464.T	Ex Dividend Junior	2023-12-28	Semi-Annually	0.00%
5563.T	Ex Dividend Junior	2023-12-28	Annually	0.00%
4486.T	Ex Dividend Knight	2023-12-28	Annually	0.00%
3661.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
2915.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
1768.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
9769.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8864.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0223	1.500	-0.445	-0.668	[0 - 0.5]
returnOnAssetsTTM	-0.0116	1.200	-0.388	-0.466	[0 - 0.3]
returnOnEquityTTM	-0.0149	1.500	-1.277	-1.915	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	4.52	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	3.24	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	1.860	1.500	0.780	1.171	[0.2 - 2]
debtRatioTTM	0.00656	-1.500	9.89	-10.00	[0 - 0.6]
interestCoverageTTM	-264.52	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	23.64	2.00	2.12	4.24	[0 - 30]
freeCashFlowPerShareTTM	23.64	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.00855	-1.500	9.97	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.470	1.000	5.50	5.50	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0190	1.000	-2.38	-2.38	[0.1 - 0.6]
cashFlowToDebtRatioTTM	8.21	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.523	0.800	9.85	7.88	[0.5 - 2]
Total Score				5.84

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-44.73	1.000	-4.62	0	[1 - 100]
returnOnEquityTTM	-0.0149	2.50	-0.821	-1.915	[0.1 - 1.5]
freeCashFlowPerShareTTM	23.64	2.00	2.12	10.00	[0 - 30]
dividendYielPercentageTTM	1.310	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	23.64	2.00	2.12	4.24	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.063	1.500	6.24	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.103	1.000	9.93	0	[0.1 - 0.5]
Total Score				3.11

Wakamoto Pharmaceutical

Wakamoto Pharmaceutical Co., Ltd. manufactures and sells ethical and non-prescription drugs in Japan. The company offers Strong Wakamoto, a gastrointestinal drug for digestion, intestinal regulation, and nutritional supplementation. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co., Ltd. in July 1943. Wakamoto Pharmaceutical Co., Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.